Home page of The Cochrane Collaboration

Home

Cochrane Review Group on HIV/AIDS

Our reviews

Click below to see our current reviews, protocols and registered titles.

Full list:

By subtopic:

Reviews of Behavioral, Social and Policy Prevention (31)
Condom use (2)
Behavioral interventions to promote condom use among women living with HIV
Structural and community-level interventions for increasing condom use to prevent HIV and other sexually transmitted infections. (protocol stage)
Drug-related HIV risk reduction (See Also: Drugs and Alcohol Group) (1)
Drug-related behavior change (1)
Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users
Interventions targeting specific populations (12)
Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women
Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low- and middle-income countries
Rapid testing for improving uptake of HIV/AIDS services in people with HIV infection (protocol stage)
Internet-based behavioral interventions for preventing HIV infection in men who have sex with men (MSM) (protocol stage)
Behavioural interventions for preventing HIV infection in homeless or unstably-housed adults (protocol stage)
Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupational settings
Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high-income countries
Information and communication technologies (ICT) for promoting sexual and reproductive health (SRH) and preventing HIV infection in adolescents and young adults (protocol stage)
Interventions to modify sexual risk behaviours for preventing HIV in homeless youth
Interventions for improving the psychosocial well-being of children affected by HIV and AIDS.
Harm reduction interventions to prevent HIV/AIDS transmission in involuntary detainees (protocol stage)
Peer-based interventions for reducing morbidity and mortality in HIV-infected women (protocol stage)
Sex-related HIV risk reduction (1)
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men
Specific types of interventions (15)
Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women
Telephone communication of HIV testing results for improving knowledge of HIV infection status
Male involvement for increasing the effectiveness of prevention of mother-to-child HIV transmission (PMTCT) programmes
Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries
Internet-based behavioral interventions for preventing HIV infection in men who have sex with men (MSM) (protocol stage)
Clinical effectiveness of school and mixed school and community based interventions for STI and HIV prevention in adolescents (protocol stage)
Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection (protocol stage)
Telephone-delivered interventions for preventing HIV infection in HIV-negative persons (protocol stage)
Information and communication technologies (ICT) for promoting sexual and reproductive health (SRH) and preventing HIV infection in adolescents and young adults (protocol stage)
Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing
Economic interventions for prevention of HIV risk and HIV infection (protocol stage)
Abstinence-only programs for HIV infection prevention in high-income countries
Abstinence-plus programs for HIV infection prevention in high-income countries
Interventions for reduction of stigma in people with HIV/AIDS (protocol stage)
Mass media interventions for promoting HIV testing
Reviews of Biomedical Prevention (20)
Antiviral suppression (2)
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Antiviral therapy for genital herpes for prevention of HIV transmission (protocol stage)
Circumcision (2)
Male circumcision for prevention of homosexual acquisition of HIV in men
Male circumcision for prevention of heterosexual acquisition of HIV in men
Condom efficacy (2)
Condom effectiveness in reducing heterosexual HIV transmission
Female condom for preventing HIV and sexually transmitted infections (protocol stage)
Microbicides (2)
Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men
Sperm washing to prevent HIV transmission from HIV-infected men but allowing conception in sero-discordant couples
Post-exposure prophylaxis (2)
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure
Effectiveness and safety of HIV post-exposure prophylaxis after sexual, injecting-drug-use or other non-occupational exposure. (protocol stage)
Pre-exposure prophylaxis (1)
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Prevention of perinatal transmission (7)
Interventions for reducing the risk of mother-to-child transmission of HIV infection
Vaginal disinfection for preventing mother-to-child transmission of HIV infection
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1
Sperm washing to prevent HIV transmission from HIV-infected men but allowing conception in sero-discordant couples
Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Interventions for preventing late postnatal mother-to-child transmission of HIV
Safety of blood products (0)
STI treatment (See also: STD Group (2)
Interventions to improve vaginal health for reducing the risk of HIV acquisition (protocol stage)
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection
Syringe and needle use (0)
Vaccines (0)
Reviews of Health Services and Care (24)
Health care characteristics (See also EPOC) (6)
Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services
Decentralising HIV treatment delivery in middle- and low-income countries (protocol stage)
Provider training and experience for people living with HIV/AIDS
Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries
Interventions for educating traditional healers about STD and HIV medicine
Setting and organization of care for persons living with HIV/AIDS
Quality of life (15)
Nutritional interventions for reducing morbidity and mortality in people with HIV
Motivational interviewing for improving outcomes in youth living with HIV
Micronutrient supplementation in pregnant women with HIV infection
Micronutrient supplementation in children and adults with HIV infection
Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection (protocol stage)
Self-management interventions for people living with HIV/AIDS (protocol stage)
Aerobic exercise interventions for adults living with HIV/AIDS
Antidepressants for depression in adults with HIV infection (protocol stage)
Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS
Massage therapy for people with HIV/AIDS
Family support for reducing morbidity and mortality in people with HIV/AIDS
Iron supplementation for reducing morbidity and mortality in children with HIV
Anabolic steroids for the treatment of weight loss in HIV-infected individuals
Cognitive behavioural therapy (CBT) for adults with HIV (protocol stage)
Progressive resistive exercise interventions for adults living with HIV/AIDS
Treatment adherence (3)
Task shifting from doctors to non-doctors for initiation and maintenance of HIV/AIDS treatment (protocol stage)
Interventions to improve adherence to antiretroviral therapy in children with HIV infection
Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS
Reviews of Therapeutics, Prognostics and Diagnostics (75)
Antiretrovirals, including protease inhibitors (23)
Combination therapy (11)
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS
Unboosted versus boosted atazanavir for reducing morbidity and mortality in people with HIV/AIDS (protocol stage)
Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection
Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection (protocol stage)
Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals
Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV (protocol stage)
HIV+ children (1)
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age
Single drugs (5)
Monoclonal CCR5 antibody for treatment of people with HIV infection
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Boosted protease inhibitor (PI) monotherapy for treating HIV/AIDS (protocol stage)
Low dose versus high dose stavudine for treating people with HIV infection (protocol stage)
Structured treatment interuptions (2)
Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults
Timing of antiretroviral therapy (4)
Optimal time for initiating antiretroviral therapy (ART) in HIV-positive, treatment-naive children aged 24 to 59 months (2 to 5 years old) (protocol stage)
Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults
Complementary Medicine (2)
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
Herbal medicines for treating HIV infection and AIDS
Diagnostics Assays (1)
Nucleic acid amplification techniques (NAATs) for early diagnosis of HIV-1 and HIV-2 infections (protocol stage)
Immunizations (5)
Human papillomavirus (HPV) vaccine for individuals with HIV infection (protocol stage)
Influenza vaccine for people with HIV/AIDS (protocol stage)
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection (protocol stage)
Measles/MMR vaccine for infants born to HIV-positive mothers (protocol stage)
Pneumococcal vaccine for prevention of Streptococcus pneumoniae infection in HIV infected persons. (protocol stage)
Prognostics Markers (3)
Routine viral load monitoring versus standard care for reducing morbidity and mortality in adolescent and adult patients living with HIV on antiretroviral therapy (ART) (protocol stage)
Therapeutic drug monitoring of antiretrovirals for people with HIV
Genotypic antiretroviral resistance testing at viral failure in people with HIV (protocol stage)
Prophylaxis and treatment of opportunistic infections (OIs) (19)
Candidiasis (3)
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection
Treatment for recurrent vulvovaginal candidiasis (thrush) (protocol stage)
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children
Cryptosporidiosis (1)
Prevention and treatment of cryptosporidiosis in immunocompromised patients
Oropharyngeal infections (2)
Topical treatments for HIV-related oral ulcers
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children
Prophylaxis (10)
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV
Optimal timing for discontinuation of Pneumocystis jiroveci pneumonia prophylaxis in adult patients on highly active antiretroviral therapy (HAART) for HIV infection (protocol stage)
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection
Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV
Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole
Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV
Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection
TB (3)
Treatment of drug-resistant tuberculosis in patients with HIV-1 infection (protocol stage)
Treatment of latent tuberculosis infection in HIV infected persons
Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus (protocol stage)
Treatment of Malignancies (6)
Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals
Treatment for Kaposi's sarcoma in children with HIV-1 infection (protocol stage)
Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adults
Treatment for leiomyosarcoma and leiomyoma in children with HIV infection
Interventions for previously untreated patients with AIDS-associated Non-Hodgkin´s Lymphoma
Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings
Treatment of other conditions (16)
Interleukin-2 as an adjunct to antiretroviral therapy for reducing morbidity and mortality in patients with HIV infection (protocol stage)
Treatment for anemia in people with AIDS
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings
Antiviral therapy for genital herpes for prevention of HIV transmission (protocol stage)
Treatment for recurrent vulvovaginal candidiasis (thrush) (protocol stage)
Pharmacological interventions for treating dyslipidemia in patients with HIV infection (protocol stage)
Management of herpes zoster ophthalmicus in people with HIV infection (protocol stage)
Antidepressants for depression in adults with HIV infection (protocol stage)
Antimicrobials for chronic AIDS-associated diarrhoea in Adults (protocol stage)
Deworming helminth co-infected individuals for delaying HIV disease progression
Effect of preventive interventions for malaria on HIV-1 disease progression in non-pregnant adults (protocol stage)
Antiviral agents for treating CMV infection of the nervous system in people with HIV (protocol stage)
Drug interventions for the treatment of lipodystrophy in patients with HIV infection (protocol stage)
Interventions for the treatment of decreased bone mineral density associated with HIV infection
Antimotility agents for chronic diarrhoea in people with HIV/AIDS
Adjunctive therapies for AIDS dementia complex
Logo of the Cochrane twentieth anniversary website
AllTrials